Sign inCreate account

Report workspace tools

NCT01607320TERMINATEDanonymous

Effect of Raloxifene on Ovulation in Women With Polycystic Ovarian Syndrome.

Sponsor

Source record

Bruce Lessey

Phase

Source record

NA

Modality

AI-normalized

small molecule

Target

AI-normalized

Raloxifene, Clomiphene

Indication / condition

AI-normalized

Polycystic Ovarian Syndrome

Intervention

Source record

Raloxifene, Clomiphene

Source & freshness

Source record

NCT ID

NCT01607320

Original source

ClinicalTrials.gov

Source last updated

Sep 20, 2018

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT01607320

Title

Effect of Raloxifene on Ovulation in Women With Polycystic Ovarian Syndrome.

Sponsor

Bruce Lessey

Status

TERMINATED

Phase

NA

Condition raw

Polycystic Ovarian Syndrome

Condition normalized

Polycystic Ovarian Syndrome

Modality raw

ovarian cancer

Modality normalized

small molecule

Target raw

Raloxifene, Clomiphene

Target normalized

Raloxifene, Clomiphene

Interventions

Raloxifene, Clomiphene

Public preview

Source record

Effect of Raloxifene on Ovulation in Women With Polycystic Ovarian Syndrome. is a NA clinical asset sponsored by Bruce Lessey in Polycystic Ovarian Syndrome. SEO and diligence focus: Raloxifene, Clomiphene, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Effect of Raloxifene on Ovulation in Women With Polycystic Ovarian Syndrome.

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT01607320

Status

TERMINATED

Phase

NA

Sponsor

Bruce Lessey

Executive brief

Investment-Ready Snapshot

Effect of Raloxifene on Ovulation in Women With Polycystic Ovarian Syndrome. is a NA clinical asset sponsored by Bruce Lessey in Polycystic Ovarian Syndrome. SEO and diligence focus: Raloxifene, Clomiphene, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedSep 20, 2018
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT01607320

Indication

Polycystic Ovarian Syndrome

Modality

small molecule

Target

Raloxifene, Clomiphene

Intervention

Raloxifene, Clomiphene

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.